Overcoming Antimicrobial Resistance: Rational Design of Rifamycin Antibiotics

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(01): 0095
DOI: 10.1055/s-0042-1752381

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Danica A. Rankic (Pfizer)

,

Nadine Kuhl (MSD)

antimicrobial resistance - rifamycin - rational drug design

Article published online:
16 December 2022

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany